Meet The Team
Sean holds a PhD in immuno-pharmacology from the University of Liverpool, focused on developing experimental and conceptual means to address T-cell mediated hypersensitivity reactions. He has long-standing links with drug safety research at Liverpool; having received the Syngenta prize for Pharmacology at degree level, and maintains an academic profile. He has several publications focused on the immuno-toxicological aspects of small molecular weight compounds and immune-checkpoint inhibitors. Sean particularly values integrating the approaches of inter-disciplinary experts in order to drive knowledge-based decision-making in drug development projects from inception to clinical delivery.